125 related articles for article (PubMed ID: 8131779)
21. Involvement of pattern recognition receptors in the induction of cytokines and reactive oxygen intermediates production by human monocytes/macrophages stimulated with tumour cells.
Mytar B; Woloszyn M; Macura-Biegun A; Hajto B; Ruggiero I; Piekarska B; Zembala M
Anticancer Res; 2004; 24(4):2287-93. PubMed ID: 15330174
[TBL] [Abstract][Full Text] [Related]
22. Nicotine modulation of cytokine induction by LPS-stimulated human monocytes and coronary artery endothelial cells.
Patton GW; Powell DA; Hakki A; Friedman H; Pross S
Int Immunopharmacol; 2006 Jan; 6(1):26-35. PubMed ID: 16332510
[TBL] [Abstract][Full Text] [Related]
23. The protective effect of serum lipoproteins against bacterial lipopolysaccharide.
Read TE; Harris HW; Grunfeld C; Feingold KR; Kane JP; Rapp JH
Eur Heart J; 1993 Dec; 14 Suppl K():125-9. PubMed ID: 8131781
[TBL] [Abstract][Full Text] [Related]
24. Role of oxidative modifications in atherosclerosis.
Stocker R; Keaney JF
Physiol Rev; 2004 Oct; 84(4):1381-478. PubMed ID: 15383655
[TBL] [Abstract][Full Text] [Related]
25. Triglyceride-rich lipoproteins prime aortic endothelium for an enhanced inflammatory response to tumor necrosis factor-alpha.
Ting HJ; Stice JP; Schaff UY; Hui DY; Rutledge JC; Knowlton AA; Passerini AG; Simon SI
Circ Res; 2007 Feb; 100(3):381-90. PubMed ID: 17234968
[TBL] [Abstract][Full Text] [Related]
26. Pioglitazone inhibits LOX-1 expression in human coronary artery endothelial cells by reducing intracellular superoxide radical generation.
Mehta JL; Hu B; Chen J; Li D
Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):2203-8. PubMed ID: 12958047
[TBL] [Abstract][Full Text] [Related]
27. [Inflammation cytokines and peroxidation of low density lipoproteins (LDL)].
Mazière JC; Mazière C
C R Seances Soc Biol Fil; 1995; 189(5):811-25. PubMed ID: 8673628
[TBL] [Abstract][Full Text] [Related]
28. Antioxidants and atherosclerotic heart disease.
Diaz MN; Frei B; Vita JA; Keaney JF
N Engl J Med; 1997 Aug; 337(6):408-16. PubMed ID: 9241131
[TBL] [Abstract][Full Text] [Related]
29. Interaction of platelets and inflammatory endothelium in the development and progression of coronary artery disease.
Langer HF; Bigalke B; Seizer P; Stellos K; Fateh-Moghadam S; Gawaz M
Semin Thromb Hemost; 2010 Mar; 36(2):131-8. PubMed ID: 20414827
[TBL] [Abstract][Full Text] [Related]
30. Modified lipoproteins, cytokines and macrovascular disease in non-insulin-dependent diabetes mellitus.
Lopes-Virella MF; Virella G
Ann Med; 1996 Aug; 28(4):347-54. PubMed ID: 8862690
[TBL] [Abstract][Full Text] [Related]
31. [Role of the immune response in atherosclerosis and acute coronary syndromes].
Caligiuri G
Med Sci (Paris); 2004 Feb; 20(2):175-81. PubMed ID: 14997437
[TBL] [Abstract][Full Text] [Related]
32. Immune mechanisms of atherosclerosis in diabetes mellitus.
Lopes-Virella MF; Virella G
Diabetes; 1992 Oct; 41 Suppl 2():86-91. PubMed ID: 1526343
[TBL] [Abstract][Full Text] [Related]
33. Cytokines, immuno-inflammatory response and atherosclerosis.
Tedgui A; Bernard C
Eur Cytokine Netw; 1994; 5(3):263-70. PubMed ID: 7948763
[TBL] [Abstract][Full Text] [Related]
34. Update on the pathogenesis of atherosclerosis.
Wissler RW
Am J Med; 1991 Jul; 91(1B):3S-9S. PubMed ID: 1867233
[TBL] [Abstract][Full Text] [Related]
35. Activation of human monocyte-derived macrophages by immune complexes containing low-density lipoprotein.
Virella G; Muñoz JF; Galbraith GM; Gissinger C; Chassereau C; Lopes-Virella MF
Clin Immunol Immunopathol; 1995 May; 75(2):179-89. PubMed ID: 7704977
[TBL] [Abstract][Full Text] [Related]
36. [New discoveries on atherosclerosis. LDL oxidation plays a central role].
Nilsson J
Lakartidningen; 1995 Oct; 92(40):3684-6, 3691. PubMed ID: 7564616
[No Abstract] [Full Text] [Related]
37. Excess TNF-α in the blood activates monocytes with the potential to directly form cholesteryl ester-laden cells.
Zhu M; Lei L; Zhu Z; Li Q; Guo D; Xu J; Chen J; Sha H; Zhang X; Yang X; Song B; Li B; Yan Y; Xiong Y
Acta Biochim Biophys Sin (Shanghai); 2015 Nov; 47(11):899-907. PubMed ID: 26373842
[TBL] [Abstract][Full Text] [Related]
38. Cytokines, modified lipoproteins, and arteriosclerosis in diabetes.
Lopes-Virella MF; Virella G
Diabetes; 1996 Jul; 45 Suppl 3():S40-4. PubMed ID: 8674888
[TBL] [Abstract][Full Text] [Related]
39. Lipoproteins do not modulate the tissue factor activity, plasminogen activator or tumour necrosis factor production induced by lipopolysaccharide stimulation of human monocytes.
Schlichting E; Henriksen T; Lyberg T
Scand J Clin Lab Invest; 1994 Oct; 54(6):465-73. PubMed ID: 7809580
[TBL] [Abstract][Full Text] [Related]
40. The role of lipoproteins in inactivation of endotoxin by serum.
Northoff H; Flegel WA; Yurttas R; Weinstock C
Beitr Infusionsther; 1992; 30():195-7. PubMed ID: 1284705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
